According to industry insiders, Mindray became the general agent of GenSure Biotech Inc., and officially started entered the SARS-CoV-2 antigen test business.

Hologic announced on Tuesday that its Aptima CMV Quant assay for cytomegalovirus has been approved by the US Food and Drug Administration.

OraSure Technologies reported after the close of the market on Tuesday that its first quarter revenues increased 16 percent year over year driven by 21 percent growth in non-COVID revenues.

Mindray started laying the foundation of the world's 4th largest manufacturing base. Runda actively invested in the construction of sampling stand for nucleic acid detection in Shanghai. Calibra accelerated the track of multi omics source innovation of clinical products

The US Food and Drug Administration said on Wednesday it has issued de novo classification to Fujirebio Diagnostics' Lumipulse G β-Amyloid Ratio (1-42/1-40) test, allowing the company to market it as a tool for diagnosing Alzheimer's disease.

BioMérieux said on Wednesday that its BioFire Joint Infection (JI) Panel has received de novo authorization from the US Food and Drug Administration.

Pfizer and BioNTech have submitted an application for Emergency Use Authorization for a COVID-19 vaccine booster dose in young children.

Existing methods for detecting and diagnosing COVID-19 are either expensive and complex or inaccurate.

Diagnostics instrument and reagent developer MicroGem announced on Tuesday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for a rapid point-of-care PCR instrument and COVID test.

On April 15, Wuhan Easy Diagnosis Biomedicine, Shenzhen YHLO Biotech and Acrobiosystemsreleased its first quarter results forecast for 2022